International Obsessive-Compulsive Disorder Foundation Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Alternative names

International Obsessive-Compulsive Disorder Foundation

Active Ingredients

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Compulsive Personality Disorder (Phase 2)

Disease (Phase 2)

Mental Disorders (Phase 2)

Obsessive-Compulsive Disorder (Phase 2)

Problem Behavior (Phase 2)

Overview

  • Highest Phase: None
  • # of Trials: 0
  • # of Trial APIs: 0